financetom
Business
financetom
/
Business
/
Ethos Technologies Insider Sold Shares Worth $2,905,411, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ethos Technologies Insider Sold Shares Worth $2,905,411, According to a Recent SEC Filing
Mar 11, 2026 2:28 AM

03:22 AM EST, 02/02/2026 (MT Newswires) -- Erin N Lantz, Chief Revenue Officer, on January 28, 2026, sold 162,677 shares in Ethos Technologies ( LIFE ) for $2,905,411. Following the Form 4 filing with the SEC, Lantz has control over a total of 253,904 Class A common shares of the company, with 253,904 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1788451/000168493626000003/xslF345X05/form4-01312026_010139.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Grindr Insider Sold Shares Worth $515,237, According to a Recent SEC Filing
Grindr Insider Sold Shares Worth $515,237, According to a Recent SEC Filing
Nov 13, 2025
04:39 PM EST, 11/13/2025 (MT Newswires) -- Austin J Balance, Chief Product Officer, on November 11, 2025, sold 34,160 shares in Grindr ( GRND ) for $515,237. Following the Form 4 filing with the SEC, Balance has control over a total of 521,082 common shares of the company, with 521,082 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1820144/000195421625000004/xslF345X05/form4-11132025_091155.xml ...
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Biopharmaceutical firm VistaGen's fiscal Q2 net loss widens
Nov 13, 2025
Overview * VistaGen fiscal Q2 net loss widens to $19.4 mln from $13.0 mln year-over-year * R&D expenses increased to $15.9 mln, driven by PALISADE Program costs * Company expects PALISADE-3 Phase 3 trial results by year-end Outlook * VistaGen expects PALISADE-3 trial results by year-end 2025 * PALISADE-4 trial results anticipated in H1 2026 Result Drivers * R&D EXPENSES...
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Huntington Ingalls Industries Insider Sold Shares Worth $4,815,900, According to a Recent SEC Filing
Nov 13, 2025
04:38 PM EST, 11/13/2025 (MT Newswires) -- Christopher D Kastner, Director, President & CEO, on November 12, 2025, sold 15,000 shares in Huntington Ingalls Industries ( HII ) for $4,815,900. Following the Form 4 filing with the SEC, Kastner has control over a total of 70,503 common shares of the company, with 2,264 shares held directly and 68,239 controlled indirectly....
TSS Q3 Swings to Loss, Revenue Declines
TSS Q3 Swings to Loss, Revenue Declines
Nov 13, 2025
04:39 PM EST, 11/13/2025 (MT Newswires) -- TSS (TSSI) reported a Q3 loss late Thursday of $0.06 per diluted share, swinging from earnings of $0.10 a year earlier. Revenue for the three months ended Sept. 30 was $41.9 million, down from $70.1 million a year earlier. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved